BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23334889)

  • 1. Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer.
    Li L; Xu DB; Zhao XL; Hao TY
    Arch Gynecol Obstet; 2013 Jul; 288(1):155-65. PubMed ID: 23334889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
    Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
    Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of budding uninhibited by benzimidazoles-1 and mitotic arrest deficient-2 in endometrial carcinoma and its significance.
    Zhao Q; Bian AP; Zhang Y; Qin L; Shi HR; Su K
    Eur J Gynaecol Oncol; 2014; 35(1):44-7. PubMed ID: 24654460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
    Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
    Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
    Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer.
    Ito K; Suzuki T; Akahira J; Sakuma M; Saitou S; Okamoto S; Niikura H; Okamura K; Yaegashi N; Sasano H; Inoue S
    Clin Cancer Res; 2005 Oct; 11(20):7384-91. PubMed ID: 16243811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade.
    Urabe R; Hachisuga T; Kurita T; Kagami S; Kawagoe T; Matsuura Y; Shimajiri S
    J Obstet Gynaecol Res; 2014 Mar; 40(3):812-9. PubMed ID: 24246002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
    Ino K; Yoshida N; Kajiyama H; Shibata K; Yamamoto E; Kidokoro K; Takahashi N; Terauchi M; Nawa A; Nomura S; Nagasaka T; Takikawa O; Kikkawa F
    Br J Cancer; 2006 Dec; 95(11):1555-61. PubMed ID: 17117179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
    Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
    Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer.
    McGrogan B; Phelan S; Fitzpatrick P; Maguire A; Prencipe M; Brennan D; Doyle E; O'Grady A; Kay E; Furlong F; McCann A
    Hum Pathol; 2014 Jul; 45(7):1509-19. PubMed ID: 24792619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF; Liu MQ; Zhao Q
    Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between the expression of dual specificity phosphatase-1 and the prognosis of endometrioid adenocarcinoma].
    Gao BR; Yao YY; Chen YH; Li XP; Wang JL; Wei LH
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2493-5. PubMed ID: 24300273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.
    Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
    Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of core 2 β1,6-N-acetylglucosaminyl transferase 1 (C2GnT1) in endometrioid-type endometrial carcinoma: a novel potential prognostic factor.
    Miyamoto T; Suzuki A; Asaka R; Ishikawa K; Yamada Y; Kobara H; Nakayama J; Shiozawa T
    Histopathology; 2013 Jun; 62(7):986-93. PubMed ID: 23617619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.
    van der Putten LJ; Visser NC; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MP; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Amant F; Massuger LF; Pijnenborg JM
    Br J Cancer; 2016 Sep; 115(6):716-24. PubMed ID: 27505134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency and significance of WT-1 expression in serous endometrial carcinoma.
    Hedley C; Sriraksa R; Showeil R; Van Noorden S; El-Bahrawy M
    Hum Pathol; 2014 Sep; 45(9):1879-84. PubMed ID: 25033726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.